DEVELOPMENT OF RENAL DOSING GUIDELINES FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND ANTIBIOTICS - A PROSPECTIVE STUDY

Maheshwari P

doi:10.22159/ajpcr.2018.v11s4.31735

Authors

Maheshwari P Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University, Pallavaram, Chennai, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11s4.31735

Keywords:

Renal dose, Guidelines, Nonsteroidal anti-inflammatory drugs, Antibiotics

Abstract

Objectives: The objectives of this study were to determine the impact of renal dosing guidelines on prescribing pattern for nonsteroidal anti-inflammatory drugs and antibiotic in patients with chronic kidney disease (CKD).

Methods: This was a prospective interventional study. The study was divided into two phases, pre-intervention and post-intervention phases. Data regarding the kidney function and the pattern of drug dosing will record in the pre-intervention phase. Pocket guides were prepared for the drug dosing in renal impairment and were distributed to clinicians and the pharmacist as a part of intervention. In the post-intervention phase, the dosing pattern of renal eliminated drugs was observed for any improvement. The patterns of dosing of renal eliminated drugs were compared in both the phases.

Results: In pre-interventional phase, a total of 43 cases were reviewed, 20 of them were non-hemodialysis (non-HD) (9 female and 11 male) cases with a meanÂ±standard deviation (SD) age of 56.05+8.22 (56) and 23 were undergoing HD (11 female and 12 male) cases with a meanÂ±SD age of 56.72+6.85 (56). In the post-intervention phase, a total of 41 cases were reviewed, 22 of them were non-HD (12 female and 10 male) cases with a meanÂ±SD age of 55.85+6.87 (57) and 19 were undergoing HD (10 female and 9 male) cases with a meanÂ±SD age of 55.77+8.39 (56.6).

Conclusion: Health-care professionals have an important responsibility in monitoring the dose for renal impairment patients. Development of renal dosing guidelines for patients hospitalized with CKD can improve the pattern of prescribing in renal failure population.

Â

Downloads

Download data is not yet available.

References

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the united states. JAMA 2007;298:2038-47.

Savage R. A dangerous trio. Prescr Update 2003;23 Suppl 2:20.

Best Practice Advocacy Centre. Acute-on-chronic kidney disease: Prevention, diagnosis, management and referral in primary care. Best Pract J 2012;46:10-5.

Maheshwari P, Usha K, Ravichandiran V, Sarumathy S. The prospective study on quality of life with assessment of heamoglobin levels in chronic kidney disease patients. Res J Pharm Biol Chem Sci 2015;6 Suppl 5:480-7.

Eknoyan G, Marketos G, De Santo NG. History of nephrology. Spyros 1997;2:235.

Malhotra R, Kashani KB, Macedo E, Kim J, Bouchard J, Wynn S, et al. A risk prediction score for acute kidney injury in the intensive care unit. Nephrol Dial Transplant 2017;32:814-22.

Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-70.

Chen S. Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely. J Am Soc Nephrol 2013;24:877-88.

Mallat J, Meddour M, Durville E, Lemyze M, Pepy F, Temime J, et al. Decrease in pulse pressure and stroke volume variations after mini-fluid challenge accurately predicts fluid responsivenessâ€ . Br J Anaesth 2015;115:449-56.

Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011;6:966-73.